BeyondSpring Inc. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-03: Form DEF 14A; Period of report 2026-10-13; Description DEFINITIVE PROXY STATEMENT; Document def14a_090226.htm.
- 2025-08-06: Form DEF 14A; Period of report 2025-09-15; Description DEF 14A; Document def14a_08062025.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-03 | DEF 14A | 2026-10-13 | DEFINITIVE PROXY STATEMENT | def14a_090226.htm |
| 2025-08-06 | DEF 14A | 2025-09-15 | DEF 14A | def14a_08062025.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |